{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:10:11Z","timestamp":1791205811146,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T00:00:00Z","timestamp":1221609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00403-008-0886-6","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T08:07:38Z","timestamp":1221552458000},"page":"551-559","source":"Crossref","is-referenced-by-count":40,"title":["Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease"],"prefix":"10.1007","volume":"300","author":[{"given":"Alessandro","family":"Borghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Fogli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Stignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Melchiorri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermete","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavio","family":"Baricordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Virgili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,17]]},"reference":[{"key":"886_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9440(10)61675-6","volume":"159","author":"S Aractingi","year":"2001","unstructured":"Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, Dubertret R, Carosella ED (2001) HLA-G and NK receptors are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 159:71\u201377","journal-title":"Am J Pathol"},{"key":"886_CR2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","volume":"101","author":"K Asadullah","year":"1998","unstructured":"Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, Volk HD, D\u00f6cke WD (1998) IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 101:783\u2013794","journal-title":"J Clin Invest"},{"key":"886_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archderm.135.2.187","volume":"135","author":"K Asadullah","year":"1999","unstructured":"Asadullah K, D\u00f6cke WD, Ebeling M, Friedrich M, Belbe G, Audring H, Volk HD, Sterry W (1999) Interleukin 10 treatment of psoriasis. Clinical results of a phase 2 trial. Arch Dermatol 135:187\u2013192","journal-title":"Arch Dermatol"},{"key":"886_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0165-0378(00)00070-X","volume":"48","author":"DR Baindbridge","year":"2000","unstructured":"Baindbridge DR, Ellis SA, Sargent IL (2000) HLA-G suppresses proliferation of CD4+ T lymphocytes. J Reprod Immunol 48:17\u201326","journal-title":"J Reprod Immunol"},{"key":"886_CR5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/ard.2006.064022","volume":"66","author":"OR Baricordi","year":"2007","unstructured":"Baricordi OR, Govoni M, Rizzo R, Trotta F (2007) In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment. Ann Rheum Dis 66:1125\u20131126","journal-title":"Ann Rheum Dis"},{"key":"886_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","volume":"5","author":"AM Bowcock","year":"2005","unstructured":"Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699\u2013711","journal-title":"Nat Rev Immunol"},{"key":"886_CR7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1523-1747.2000.00919.x","volume":"114","author":"DW Brown","year":"2000","unstructured":"Brown DW, Baker BS, Ovigne JM, Hardman C, Powles AV, Fry L (2000) Skin CD4+ T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis. J Invest Dermatol 114:576\u2013580","journal-title":"J Invest Dermatol"},{"key":"886_CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1471-4906(01)02007-5","volume":"22","author":"ED Carosella","year":"2001","unstructured":"Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N (2001) HLA-G: a shield against inflammatory aggression. Trends Immunol 22:553\u2013555","journal-title":"Trends Immunol"},{"key":"886_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clim.2007.01.006","volume":"123","author":"FC Chong","year":"2007","unstructured":"Chong FC, Wong HK (2007) Immunobiologics in the treatment of psoriasis. Clin Immunol 123:129\u2013138","journal-title":"Clin Immunol"},{"key":"886_CR10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.humimm.2003.08.356","volume":"11","author":"C Creput","year":"2003","unstructured":"Creput C, Le Friec G, Bahri R, Amiot L, Charpentier B, Carosella ED, Rouas-Freiss N, Durrbach A (2003) Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver- kidney transplantation: possible implications for monitoring patients. Hum Immunol 11:1033\u20131038","journal-title":"Hum Immunol"},{"key":"886_CR11","first-page":"10171","volume":"138","author":"RS Dawe","year":"2002","unstructured":"Dawe RS, Cameron H, Yule S, Man I, Ibbotson SH, Ferguson J (2002) UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 138:10171\u201310176","journal-title":"Arch Dermatol"},{"key":"886_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002960050111","volume":"19","author":"O Elkayam","year":"2000","unstructured":"Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D (2000) Serum levels of IL-10, IL-6, IL-1R and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 19:101\u2013105","journal-title":"Rheumatol Int"},{"key":"886_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-5728(03)00266-2","volume":"142","author":"E Fainardi","year":"2003","unstructured":"Fainardi E, Rizzo R, Melchiorri L, Vaghi L, Castellazzi M, Marzola A, Govoni V, Paolino E, Tola MR, Granieri E, Baricordi OR (2003) Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 142:149\u2013158","journal-title":"J Neuroimmunol"},{"key":"886_CR14","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.4049\/jimmunol.164.12.6100","volume":"164","author":"S Fournel","year":"2000","unstructured":"Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P (2000) Cutting edge: soluble HLA-G1 triggers CD95\/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164:6100\u20136104","journal-title":"J Immunol"},{"key":"886_CR15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1523-1747.2002.01731.x","volume":"118","author":"M Friedrich","year":"2002","unstructured":"Friedrich M, D\u00f6cke WD, Klein A, Philipp S, Volk HD, Sterry W, Asadullah H (2002) Immunomodulation by Interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis. J Invest Dermatol 118:672\u2013677","journal-title":"J Invest Dermatol"},{"key":"886_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humimm.2003.09.019","volume":"65","author":"E Gazit","year":"2004","unstructured":"Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R (2004) HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol 65:39\u201346","journal-title":"Hum Immunol"},{"key":"886_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/intimm\/13.3.385","volume":"13","author":"A Horuzko","year":"2001","unstructured":"Horuzko A, Lenfant F, Munn DH, Mellor AL (2001) Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13:385\u2013394","journal-title":"Int Immunol"},{"key":"886_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","volume":"55","author":"TV Hviid","year":"2003","unstructured":"Hviid TV, Hylenius S, Rorbye C, Nielsen LG (2003) HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55:63\u201379","journal-title":"Immunogenetics"},{"key":"886_CR19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00251-004-0673-2","volume":"56","author":"TV Hviid","year":"2004","unstructured":"Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR (2004) HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 56:135\u2013141","journal-title":"Immunogenetics"},{"key":"886_CR20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1399-0039.2002.600202.x","volume":"60","author":"TV Hviid","year":"2002","unstructured":"Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB (2002) HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 60:122\u2013132","journal-title":"Tissue Antigens"},{"key":"886_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09629350310001619753","volume":"12","author":"SE Jacob","year":"2003","unstructured":"Jacob SE, Nassiri M, Kerdel FA, Vincek V (2003) Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm 12:309\u2013313","journal-title":"Mediators Inflamm"},{"key":"886_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000077660","volume":"208","author":"D Jullien","year":"2004","unstructured":"Jullien D, Prinz JC, Langley RG, Caro I, Dummer W, Joshi A, Dedrick R, Natta P (2004) T-cell modulation for the treatment of chronic plaque psoriasis with Efalizumab (Raptiva): mechanisms of action. Dermatology 208:297\u2013306","journal-title":"Dermatology"},{"key":"886_CR23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.0022-202x.2001.01487.x","volume":"17","author":"K Khosrotehrani","year":"2001","unstructured":"Khosrotehrani K, Le Danff C, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S (2001) HLA-G expression in atopic dermatitis. J Invest Dermatol 17:750\u2013752","journal-title":"J Invest Dermatol"},{"key":"886_CR24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","volume":"248","author":"S Kovats","year":"1990","unstructured":"Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220\u2013223","journal-title":"Science"},{"key":"886_CR25","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1074\/jbc.M008496200","volume":"276","author":"S Lefebvre","year":"2001","unstructured":"Lefebvre S, Berrih-Akin S, Adrian F, Moreau P, Poea S, Gourand L, Dausset J, Carosella ED, Paul P (2001) A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem 276:6133\u20136139","journal-title":"J Biol Chem"},{"key":"886_CR26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0198-8859(03)00091-0","volume":"64","author":"G Le Friec","year":"2003","unstructured":"Le Friec G, Laupeze B, Fardel O, Sebti Y, Pangault C, Guilloux V, Beauplet A, Fauchet R, Amiot L (2003) Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Human Immunol 64:752\u2013761","journal-title":"Human Immunol"},{"key":"886_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","volume":"25","author":"W Lew","year":"2004","unstructured":"Lew W, Bowcock AM, Krueger JG (2004) Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and \u201cType 1\u201d inflammatory gene expression. Trends Immunol 25:295\u2013305","journal-title":"Trends Immunol"},{"key":"886_CR28","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","volume":"105","author":"N Lila","year":"2002","unstructured":"Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A (2002) Human leukocyte antigen -G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105:1949\u20131954","journal-title":"Circulation"},{"key":"886_CR29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0039.2003.00143.x","volume":"62","author":"J LeMaoult","year":"2003","unstructured":"LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, McCluskey J, Carosella ED (2003) Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62:273\u2013284","journal-title":"Tissue Antigens"},{"key":"886_CR30","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1073\/pnas.0401922101","volume":"101","author":"J LeMaoult","year":"2004","unstructured":"LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED (2004) HLA-G1-espressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Prot Natl Acad Sci USA 101:7064\u20137069","journal-title":"Prot Natl Acad Sci USA"},{"key":"886_CR31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200202150-00005","volume":"16","author":"JM Lozano","year":"2002","unstructured":"Lozano JM, Gonzales R, Kindelan JM, Rouas-Freiss N, Caballos R, Dausset J, Carosella ED, Pe\u0148a J (2002) Monocytes and T lymphocytes in HIV-1 positive patients express HLA-G molecules. AIDS 16:347\u2013351","journal-title":"AIDS"},{"key":"886_CR32","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0041-1345(99)00186-4","volume":"41","author":"S Maier","year":"1999","unstructured":"Maier S, Geraghty DE, Weiss EH (1999) Expression and regulation of HLA-G in human glioma cells. Transplant Proc 41:1849\u20131853","journal-title":"Transplant Proc"},{"key":"886_CR33","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0190-9622(03)01134-4","volume":"49","author":"SL Mehlis","year":"2003","unstructured":"Mehlis SL, Gordon KB (2003) The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 49:S44\u2013S50","journal-title":"J Am Acad Dermatol"},{"key":"886_CR34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/11.5.803","volume":"5","author":"P Moreau","year":"1999","unstructured":"Moreau P, Adrian-Cabestre F, Menier C, Guiard U, Gourand L, Dausset J, Carosella ED, Paul P (1999) IL-10 selectively induces HLA-G expression in human trophoblast and monocytes. Int Immunol 5:803\u2013811","journal-title":"Int Immunol"},{"key":"886_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12016-007-0039-2","volume":"33","author":"BJ Nickoloff","year":"2007","unstructured":"Nickoloff BJ, Jian-Zhong Q, Nestle FO (2007) Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 33:45\u201356","journal-title":"Clin Rev Allergy Immunol"},{"key":"886_CR36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/clin.1994.1170","volume":"73","author":"BJ Nickoloff","year":"1994","unstructured":"Nickoloff BJ, Fivenson DP, Kunkel SL, Strieter RM, Turka LA (1994) Keratinocyte IL-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. Clin Immunol Immunopathol 73:63\u201368","journal-title":"Clin Immunol Immunopathol"},{"key":"886_CR37","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.164.12.6426","volume":"164","author":"M Onno","year":"2000","unstructured":"Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R (2000) Modulation of HLA-G antigen expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164:6426\u20136434","journal-title":"J Immunol"},{"key":"886_CR38","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","volume":"95","author":"P Paul","year":"1998","unstructured":"Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95:4510\u20134515","journal-title":"Proc Natl Acad Sci USA"},{"key":"886_CR39","first-page":"1954","volume":"59","author":"P Paul","year":"1999","unstructured":"Paul P, Cabestre FA, Le Gal FA, Khalil-Daher I, Le Danff C, Shmid M, Mercier S, Avril MF, Dausset J, Guillet JG, Carosella ED (1999) Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res 59:1954\u20131960","journal-title":"Cancer Res"},{"key":"886_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1034\/j.1399-0039.2001.057001015.x","volume":"57","author":"V Rebmann","year":"2001","unstructured":"Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H (2001) Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57:15\u201321","journal-title":"Tissue Antigens"},{"key":"886_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1399-0039.2006.763_5.x","volume":"69","author":"V Rebmann","year":"2007","unstructured":"Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H (2007) Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 69:143\u2013149","journal-title":"Tissue Antigens"},{"key":"886_CR42","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1073\/pnas.94.10.5249","volume":"94","author":"N Rouas-Freiss","year":"1997","unstructured":"Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED (1997) The \u03b11 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249\u20135254","journal-title":"Proc Natl Acad Sci USA"},{"key":"886_CR43","first-page":"169","volume":"25","author":"AV Roussaki-Schulze","year":"2005","unstructured":"Roussaki-Schulze AV, Kouskoukis C, Petinaki E, Klimi E, Zafiriou E, Galanos A, Rallis E (2005) Evaluation of cytokine serum levels in patients with plaque-type psoriasis. Int J Clin Pharmacol Res 25:169\u2013173","journal-title":"Int J Clin Pharmacol Res"},{"key":"886_CR44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.humimm.2003.08.347","volume":"64","author":"P Rousseau","year":"2003","unstructured":"Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P (2003) The 14\u00a0bp deletion-insertion polymorphism in the 3\u2019 UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64:1005\u20131010","journal-title":"Hum Immunol"},{"key":"886_CR45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","volume":"16","author":"R Sabat","year":"2007","unstructured":"Sabat R, Philipp S, H\u00f6flich C, Kreutzer S, Wallace E, Asadullah K, Volk HD, Sterry W, Wolk K (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16:779\u2013798","journal-title":"Exp Dermatol"},{"key":"886_CR46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","volume":"174","author":"H Sugijama","year":"2005","unstructured":"Sugijama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens SR, McCormick TS, Cooper KD (2005) Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174:164\u2013173","journal-title":"J Immunol"},{"key":"886_CR47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.semcancer.2007.09.001","volume":"17","author":"M Urosevic","year":"2007","unstructured":"Urosevic M (2007) HLA-G in the skin. Friend or foe ? Semin Cancer Biol 17:480\u2013484","journal-title":"Semin Cancer Biol"},{"key":"886_CR48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.humimm.2006.03.023","volume":"67","author":"LA Verbruggen","year":"2006","unstructured":"Verbruggen LA, Rebman V, Demanet C, De Cock S, Grosse-Wilde H (2006) Soluble HLA-G in rheumatoid arthritis. Hum Immunol 67:561\u2013567","journal-title":"Hum Immunol"},{"key":"886_CR49","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00403-005-0559-7","volume":"296","author":"P Weisenseel","year":"2005","unstructured":"Weisenseel P, Prinz JC (2005) Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR. Arch Dermatol Res 296:573\u2013576","journal-title":"Arch Dermatol Res"},{"key":"886_CR50","first-page":"46","volume":"1","author":"SM Yie","year":"2006","unstructured":"Yie SM, Xiao R, Librach CL (2006) Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Hum Reprod 1:46\u201351","journal-title":"Hum Reprod"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-008-0886-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0886-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T08:46:07Z","timestamp":1588927567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-008-0886-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,17]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1007\/s00403-008-0886-6","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,17]]}}}